OxyContin Being Tested On Kids... So Drugmaker Can Get 6 More Months Of Patent Protection

from the skewed-priorities dept

Want a sense of just how screwed up the incentives of our patent system are today? Purdue Pharma, the makers of the highly addictive painkiller OxyContin, is now running clinical tests to get the FDA to approve its use for kids as young as 6-years-old. Why? Because the Federal Food, Drug, and Cosmetic Act section 505A includes a little "gift": if drugmakers conduct clinical studies for their drugs with kids, they can get six more months of patent protection. So even if they don't even sell OxyContin to six year olds, just securing the extended patent, thanks to the massive monopoly rents given to drugs still on patent, Purdue is likely to profit massively. Lots of people are reasonably troubled by this:
“They are doing (the pediatric trial) for patent exclusivity, there’s no doubt about it in my mind — not out of largesse,” said Dr. Elliot Krane, director of pain management at Lucile Packard Children’s Hospital at Stanford University in Palo Alto, Calif. “That’s important for their bottom line.”
Of course, some will argue that if this provides better drug availability to kids, and those drugs really help the kids, then perhaps this isn't a bad thing. But, no matter what, the incentives here are highly questionable.

Filed Under: clinical trials, drug patents, fda, oxycontin
Companies: purdue pharma


Reader Comments

Subscribe: RSS

View by: Time | Thread


  1. icon
    DannyB (profile), 5 Jul 2012 @ 2:10pm

    Re: Re:

    I believe the difference is that oxycodone is not time release.

Add Your Comment

Have a Techdirt Account? Sign in now. Want one? Register here



Subscribe to the Techdirt Daily newsletter




Comment Options:

  • Use markdown. Use plain text.
  • Remember name/email/url (set a cookie)

Follow Techdirt
Techdirt Gear
Show Now: Takedown
Advertisement
Report this ad  |  Hide Techdirt ads
Essential Reading
Techdirt Deals
Report this ad  |  Hide Techdirt ads
Techdirt Insider Chat
Advertisement
Report this ad  |  Hide Techdirt ads
Recent Stories
Advertisement
Report this ad  |  Hide Techdirt ads

Close

Email This

This feature is only available to registered users. Register or sign in to use it.